Reportlinker finds all market research
reports published by official sources!

U.S. Diabete Industry (diabete, obesity)

  • This 26-page industry report was published in December 2011.
... as well as 436 Pathology industry reports, company profiles and country guides published by official sources (government, embassies, trade unions...).

Privacy Policy by TRUSTe

We value your privacy and will never rent or sell your email address. Privacy Policy by TRUSTe

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Sam

(866) 682 9815

Share


Pathology Industry in the United States : Latest Downloads

Pharmaceutical Sector in The United States

Pharmaceutical Sector in The United States

  • Industry report
  • May 2013
  • 6 pages
  • by Governmental Agency

... Such as heart attack, stroke, heart failure and end-stage kidney failure.13 cardiovascular diseases are costly to society; direct and indirect costs of cardiovascular diseases in the u.S. Are estimated ...

U.S. Pharmaceutical Business

U.S. Pharmaceutical Business

  • Industry report
  • May 2013
  • 33 pages
  • by Corporation

... Annually. Diabetic foot ulcers lead to over 82,000 amputations annually at a cost that are estimated to exceed $3.6 Billion annually. Hospitalization costs of ~$20,000 for a patient with a dfu; ~$60 ...

Pharmaceutical in The United States : Innovation and Technology Trends

Pharmaceutical in The United States : Innovation and Technology Trends

  • Industry report
  • May 2013
  • 41 pages

... As a collaborative program that will utilize a combination of next generation sequencing and related genomic technologies, capabilities and computational analyses to understand infectious ...



Pathology Industry in the United States : Latest Reports

EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022

EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • March 2013
  • by Global Data

EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022 Summary Cystic fibrosis (CF) is the most common inherited rare disease in North America and Europe, with more than 27,000 cases in the ...

Lyrica (Epilepsy) - Forecast and Market Analysis to 2022

Lyrica (Epilepsy) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • February 2013
  • by Global Data

Lyrica (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Lyrica (Epilepsy) - Forecast and Market Analysis to 2022?. Epilepsy ...

Hemoglobin A1c Testing Markets

Hemoglobin A1c Testing Markets

  • $ 3 400
  • Industry report
  • March 2013
  • by TriMark Publications

Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes mellitus continues to increase rapidly, with more than ...


Company Profiles

9 Companies

UCL Union

United Kingdom

Wolters Kluwer N.V.

Netherlands

Bristol-Myers Squibb Co.

United States

Pfizer Inc.

United States

Spherix Inc.

United States

Proskauer Rose L.L.P.

United States

Fabricut Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.